Constanze Heinzel
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Mucosal response of inactivated and recombinant COVID-19 vaccines in Congolese individuals.
Journal: Immunity, inflammation and disease
Published: July 21, 2023
Saliva and Plasma Antibody Levels in Children and Adolescents After Primary Infection With Omicron Variants of SARS-CoV-2 Infection in Germany.
Journal: JAMA pediatrics
Published: April 17, 2023
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2.
Journal: The Lancet. Microbe
Published: September 05, 2022
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 11, 2022
SARS-CoV-2 Antibodies Are Persisting in Saliva for More Than 15 Months After Infection and Become Strongly Boosted After Vaccination.
Journal: Frontiers in immunology
Published: October 20, 2021
Non-Invasive Antibody Assessment in Saliva to Determine SARS-CoV-2 Exposure in Young Children.
Journal: Frontiers in immunology
Published: August 04, 2021
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.
Journal: Nature communications
Published: March 08, 2021
Prevalence of SARS-CoV-2 Infection in Children by Antibody Detection in Saliva: Protocol for a Prospective Longitudinal Study (Coro-Buddy).
Journal: JMIR research protocols
Published: February 04, 2021
Complementary methods for SARS-CoV-2 diagnosis in times of material shortage.
Journal: Scientific reports
Published: December 07, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026